verified SJR 1,166 · Q1 • database Scopus / SJR & Web of Science indexed

Netherlands · SAGE Publications Ltd

workspace_premium Q1 — Medicine (miscellaneous) lock Subscription

Journal of Alzheimer's Disease

Journal of Alzheimer's Disease is a journal indexed in SJR in Medicine (miscellaneous) and Neuroscience (miscellaneous) with an H index of 188. It has an SJR impact factor of 1,166 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,166.

Journal of Alzheimer's Disease focuses its scope in these topics and keywords: alzheimer’s, disease, dementia, cognitive, impairment, mild, amyloid?, cerebrospinal, frontotemporal, patients, ...

ISSN: 1387-2877

Publisher: SAGE Publications Ltd

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,166 Q1

H-index 188

Acceptance rate pie_chart

21% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,166

H-index

188

Docs (year)

794

Docs 3y

2461

Total refs

36134

Cites 3y

8663

Citable 3y

2450

Cites/Doc 2y

3.01

Ref/Doc

45.51

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Analysis of Salivary Microbiome in Patients with Alzheimer's Disease

Visit-to-Visit Blood Pressure Variability and Alzheimer's Disease: Links and Risks

Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease

Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team

Central and Peripheral Administration of Antisense Oligonucleotide Targeting Amyloid-beta Protein Precursor Improves Learning and Memory and Reduces Neuroinflammatory Cytokines in Tg2576 (AbetaPPswe) Mice

Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease

Blood Genome-Wide Transcriptional Profiles Reflect Broad Molecular Impairments and Strong Blood-Brain Links in Alzheimer's Disease

Behavioral and Neuropsychiatric Disorders in Alzheimer's Disease

AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders

Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People

Association between a-Klotho and Deep White Matter Lesions in the Brain: A Pilot Case Control Study Using Brain MRI

Assessing the Toxicity of Tau Aggregation

SHOW MORE ARTICLES

Are Major Dementias Triggered by Poor Blood Flow to the Brain? Theoretical Considerations

A Natural Benzofuran from the Patagonic Aleurodiscus vitellinus Fungus has Potent Neuroprotective Properties on a Cellular Model of Amyloid-beta Peptide Toxicity

Amyloid-beta/Drug Interactions from Computer Simulations and Cell-Based Assays

Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults

Altered Transcriptional Profile of Mitochondrial DNA-Encoded OXPHOS Subunits, Mitochondria Quality Control Genes, and Intracellular ATP Levels in Blood Samples of Patients with Parkinson's Disease

Altered Neurotransmission Prior to Cognitive Decline in AbetaPP/PS1 Mice, a Model of Alzheimer's Disease

Albumin-Blunted Deleterious Effect of Amyloid-beta by Preventing the Internalization of the Peptide into Neurons

Age-Related Alterations in the Metabolic Profile in the Hippocampus of the Senescence-Accelerated Mouse Prone 8: A Spontaneous Alzheimer's Disease Mouse Model

Age-Dependent Increment of Hydroxymethylation in the Brain Cortex in the Triple-Transgenic Mouse Model of Alzheimer's Disease

Adiposity, Weight Change, and Risk of Cognitive Impairment: The Singapore Chinese Health Study

Aberrant Co-localization of Synaptic Proteins Promoted by Alzheimer's Disease Amyloid-beta Peptides: Protective Effect of Human Serum Albumin

ABCA7 Genotype Moderates the Effect of Aerobic Exercise Intervention on Generalization of Prior Learning in Healthy Older African Americans

FAQs

Journal of Alzheimer's Disease has an SJR of 1,166 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Journal of Alzheimer's Disease is 21%.

Journal of Alzheimer's Disease

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Journal of Alzheimer's Disease?

What is the APC / publication cost?

What is the acceptance rate?